BioPharmSignal logoBioPharmSignal

Biotech News

T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024

T2 Biosystems (TTOO)T2 BiosystemsEarnings

LEXINGTON, Mass. , Nov. 05, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the third quarter 2024 and business updates after market

Related news

MDXHMDxHealth2025-11-03 21:01 EST

Mdxhealth to Release Third Quarter 2025 Financial Results on November 12

BDSXBiodesix2026-02-12 11:00 EST

Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

SERASera Prognostics2026-07-29 20:05 EST

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026

BRLIBio-Reference Laboratories2026-07-27 20:05 EST

OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results

BRLIBio-Reference Laboratories2026-07-23 16:30 EST

OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026

OSUROraSure Technologies, Inc.2026-07-22 20:10 EST

OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th

BDSXBiodesix2026-07-22 10:00 EST

Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026

OSUROraSure Technologies, Inc.2026-04-22 20:10 EST

OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th

XGNExagen2026-02-24 14:00 EST

Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

FLGTFulgent Genetics, Inc.2026-02-12 12:30 EST

Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026

View all latest news

T2 Biosystems

T2 Biosystems is a medical diagnostics company focused on rapid pathogen detection and bloodstream infection testing. Its business is centered on delivering fast diagnostic information to clinical settings.

Recent company news

TTOOT2 Biosystems2025-01-07 14:00 EST

T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

TTOOT2 Biosystems2024-12-18 14:00 EST

T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor

TTOOT2 Biosystems2024-12-17 14:00 EST

T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally

TTOOT2 Biosystems2024-12-16 14:00 EST

T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.

TTOOT2 Biosystems2024-12-09 14:00 EST

T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

Stock data

Close
0.00 USD
Market cap
—
Exchange
NASDAQ
Sector
MedTech
Location
United States